5.9 C
New York
Friday, March 29, 2024

United Therapeutics Gets Favorable Ruling, Shares Flying Higher

Courtesy of Benzinga.

Related UTHR
Earnings Scheduled For July 29, 2014
Weakness Seen In United Therapeutics: Stock Tumbles 8.0% – Tale Of The Tape

Shares of United Therapeutics (NASDAQ: UTHR) are trading sharply higher on news that patent infringement ruling against competitor Sandoz.

The ruling disallows Sandoz to sell the generic version of United Therapeutics hypertension drug Remodulin before 2017.

Shares were trading up more than 24 percent to $114.47.

Posted-In: News Legal Movers

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,450FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x